Literature DB >> 33426751

Psychomotor processing and functional decline in Parkinson's disease predicted by the Purdue Pegboard test.

Jared T Hinkle1,2, Gregory M Pontone2.   

Abstract

BACKGROUND: The Purdue Pegboard test (PPT) assesses upper-extremity dexterity and motor skills. We hypothesized that PPT skill would predict functional and cognitive decline in Parkinson's disease (PD), independent of observer-rated measures of motor impairment.
METHODS: We utilized data from 399 PD participants enrolled in the deprenyl and tocopherol antioxidative therapy of Parkinsonism trial. Unified Parkinson Disease Rating Scale (UPDRS) metrics, neuropsychological assessments, and clinical rating scales were extracted for analysis with multivariate linear mixed-effects and generalized estimating equation regression models.
RESULTS: In multivariate logistic regression, higher baseline and time-varying PPT scores predicted better visual processing speed and attention throughout longitudinal follow-up. No similarly strong associations were found for tests of memory, nonvisual attention, phonemic fluency, or set-shifting. Independently of observer-rated motor impairment (UPDRS part III), PPT performance was significantly associated with changes in activities of daily living (ADL) function measured with UPDRS part II. Low baseline PPT score (≤10th percentile) doubled the relative risk of later ADL dysfunction (≥90th percentile).
CONCLUSIONS: PPT impairment selectively predicted declining psychomotor processing speed in PD. The domain-specificity of this association may reflect correlated pathophysiological changes in top-down visual and motor control pathways. PPT also predicted increasing ADL dysfunction after adjusting for objective measures of motor impairment. We suggest that PPT scores may be prognostically useful for predicting cognitive changes and ADL dysfunction, which have dramatic impacts on both patient and caregiver quality of life. Furthermore, simple task-based assessments like the PPT could be investigated for remote assessment in PD.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; Purdue Pegboard test; cognitive domains; cognitive impairment; functional impairment; neuropsychological tests; visual processing

Mesh:

Year:  2021        PMID: 33426751      PMCID: PMC8102321          DOI: 10.1002/gps.5492

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.850


  20 in total

1.  The Purdue pegboard; norms and studies of reliability and validity.

Authors:  J TIFFIN; E J ASHER
Journal:  J Appl Psychol       Date:  1948-06

2.  The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Monica M Kurtis; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

3.  The Purdue Pegboard Test: normative data for people aged 60 and over.

Authors:  J Desrosiers; R Hébert; G Bravo; E Dutil
Journal:  Disabil Rehabil       Date:  1995-07       Impact factor: 3.033

4.  The effect of Parkinson's disease on the ability to maintain a mental set.

Authors:  K A Flowers; C Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

Review 5.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

Review 6.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

7.  Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease.

Authors:  Bernd Müller; Jörg Assmus; Karen Herlofson; Jan Petter Larsen; Ole-Bjørn Tysnes
Journal:  Parkinsonism Relat Disord       Date:  2013-08-02       Impact factor: 4.891

Review 8.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.

Authors:  Angie A Kehagia; Roger A Barker; Trevor W Robbins
Journal:  Lancet Neurol       Date:  2010-09-27       Impact factor: 44.182

9.  Predictors of cognitive impairment in an early stage Parkinson's disease cohort.

Authors:  Michele T M Hu; Konrad Szewczyk-Królikowski; Paul Tomlinson; Kannan Nithi; Michal Rolinski; Clara Murray; Kevin Talbot; Klaus P Ebmeier; Clare E Mackay; Yoav Ben-Shlomo
Journal:  Mov Disord       Date:  2014-01-06       Impact factor: 10.338

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.